Modification of a melanoma discrimination index derived from hyperspectral data: A clinical trial conducted in 2 centers between March 2011 and December 2013

T. Nagaoka, Y. Kiyohara, H. Koga, Atsushi Nakamura, T. Saida, Takayuki Sota

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The morphology of pigmented skin lesions (PSLs) is predominantly a result of varying concentrations and distributions of pigmented molecules such as melanin and hemoglobin. Based on these differences and the fact that their information is contained in cutaneous spectra, a hyperspectral imager (HSI) for pigmented melanoma and a single discrimination index derived from the resultant hyperspectral data are proposed. Objective: To develop and evaluate a new discrimination index for melanomas, compared to the previous index. Methods: A HSI, which is convenient for both patients and clinicians, was newly developed and used in a clinical trial conducted in 2 centers with 80 patients with primary lesions and 17 volunteers between March 2011 and December 2013. There were 24 melanomas and 110 other PSLs. A previously proposed discrimination index was used without modifications. A new index, which emphasized the essential features of melanoma, was proposed, and its performance was examined. For each index, a threshold value was set to minimize the average value of the false positive and false negative fractions. The performances of both indices were compared. Results: The sensitivity and specificity of the old index were 75% and 97%, respectively, while those of the new index were 96% and 87%. Conclusion: The new index had a higher sensitivity and adequate specificity, indicating that it is more useful than the old index.

Original languageEnglish
Pages (from-to)278-283
Number of pages6
JournalSkin Research and Technology
Volume21
Issue number3
DOIs
Publication statusPublished - 2015 Aug 1

Fingerprint

Melanoma
Clinical Trials
Skin
Sensitivity and Specificity
Melanins
Volunteers
Hemoglobins

Keywords

  • Computer-assisted diagnosis
  • Early detection of melanoma
  • Melanoma
  • Spectrum analysis

ASJC Scopus subject areas

  • Dermatology

Cite this

Modification of a melanoma discrimination index derived from hyperspectral data : A clinical trial conducted in 2 centers between March 2011 and December 2013. / Nagaoka, T.; Kiyohara, Y.; Koga, H.; Nakamura, Atsushi; Saida, T.; Sota, Takayuki.

In: Skin Research and Technology, Vol. 21, No. 3, 01.08.2015, p. 278-283.

Research output: Contribution to journalArticle

@article{a76ceb6f2f32434db83f069bd5860c86,
title = "Modification of a melanoma discrimination index derived from hyperspectral data: A clinical trial conducted in 2 centers between March 2011 and December 2013",
abstract = "Background: The morphology of pigmented skin lesions (PSLs) is predominantly a result of varying concentrations and distributions of pigmented molecules such as melanin and hemoglobin. Based on these differences and the fact that their information is contained in cutaneous spectra, a hyperspectral imager (HSI) for pigmented melanoma and a single discrimination index derived from the resultant hyperspectral data are proposed. Objective: To develop and evaluate a new discrimination index for melanomas, compared to the previous index. Methods: A HSI, which is convenient for both patients and clinicians, was newly developed and used in a clinical trial conducted in 2 centers with 80 patients with primary lesions and 17 volunteers between March 2011 and December 2013. There were 24 melanomas and 110 other PSLs. A previously proposed discrimination index was used without modifications. A new index, which emphasized the essential features of melanoma, was proposed, and its performance was examined. For each index, a threshold value was set to minimize the average value of the false positive and false negative fractions. The performances of both indices were compared. Results: The sensitivity and specificity of the old index were 75{\%} and 97{\%}, respectively, while those of the new index were 96{\%} and 87{\%}. Conclusion: The new index had a higher sensitivity and adequate specificity, indicating that it is more useful than the old index.",
keywords = "Computer-assisted diagnosis, Early detection of melanoma, Melanoma, Spectrum analysis",
author = "T. Nagaoka and Y. Kiyohara and H. Koga and Atsushi Nakamura and T. Saida and Takayuki Sota",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/srt.12188",
language = "English",
volume = "21",
pages = "278--283",
journal = "Skin Research and Technology",
issn = "0909-752X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Modification of a melanoma discrimination index derived from hyperspectral data

T2 - A clinical trial conducted in 2 centers between March 2011 and December 2013

AU - Nagaoka, T.

AU - Kiyohara, Y.

AU - Koga, H.

AU - Nakamura, Atsushi

AU - Saida, T.

AU - Sota, Takayuki

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background: The morphology of pigmented skin lesions (PSLs) is predominantly a result of varying concentrations and distributions of pigmented molecules such as melanin and hemoglobin. Based on these differences and the fact that their information is contained in cutaneous spectra, a hyperspectral imager (HSI) for pigmented melanoma and a single discrimination index derived from the resultant hyperspectral data are proposed. Objective: To develop and evaluate a new discrimination index for melanomas, compared to the previous index. Methods: A HSI, which is convenient for both patients and clinicians, was newly developed and used in a clinical trial conducted in 2 centers with 80 patients with primary lesions and 17 volunteers between March 2011 and December 2013. There were 24 melanomas and 110 other PSLs. A previously proposed discrimination index was used without modifications. A new index, which emphasized the essential features of melanoma, was proposed, and its performance was examined. For each index, a threshold value was set to minimize the average value of the false positive and false negative fractions. The performances of both indices were compared. Results: The sensitivity and specificity of the old index were 75% and 97%, respectively, while those of the new index were 96% and 87%. Conclusion: The new index had a higher sensitivity and adequate specificity, indicating that it is more useful than the old index.

AB - Background: The morphology of pigmented skin lesions (PSLs) is predominantly a result of varying concentrations and distributions of pigmented molecules such as melanin and hemoglobin. Based on these differences and the fact that their information is contained in cutaneous spectra, a hyperspectral imager (HSI) for pigmented melanoma and a single discrimination index derived from the resultant hyperspectral data are proposed. Objective: To develop and evaluate a new discrimination index for melanomas, compared to the previous index. Methods: A HSI, which is convenient for both patients and clinicians, was newly developed and used in a clinical trial conducted in 2 centers with 80 patients with primary lesions and 17 volunteers between March 2011 and December 2013. There were 24 melanomas and 110 other PSLs. A previously proposed discrimination index was used without modifications. A new index, which emphasized the essential features of melanoma, was proposed, and its performance was examined. For each index, a threshold value was set to minimize the average value of the false positive and false negative fractions. The performances of both indices were compared. Results: The sensitivity and specificity of the old index were 75% and 97%, respectively, while those of the new index were 96% and 87%. Conclusion: The new index had a higher sensitivity and adequate specificity, indicating that it is more useful than the old index.

KW - Computer-assisted diagnosis

KW - Early detection of melanoma

KW - Melanoma

KW - Spectrum analysis

UR - http://www.scopus.com/inward/record.url?scp=84937022426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937022426&partnerID=8YFLogxK

U2 - 10.1111/srt.12188

DO - 10.1111/srt.12188

M3 - Article

C2 - 25131159

AN - SCOPUS:84937022426

VL - 21

SP - 278

EP - 283

JO - Skin Research and Technology

JF - Skin Research and Technology

SN - 0909-752X

IS - 3

ER -